Human gene
MYH7 myosin, heavy chain 7, cardiac muscle, beta
2 disease groups in OMIA reach this gene, through the animal gene that Ensembl gives as its ortholog. The page shows the chain. It does not say whether an animal is a model of a human disease.
Animal diseases
By each group's best natural-model score, highest first. How the score works.
| OMIA group | Name | Species | Animal gene | Ortholog | The chain reached | Best score |
|---|---|---|---|---|---|---|
| 1200 | Tremor, high-frequency | pig | MYH7 | one to one | Drug |
62.5
|
| 2212 | Cardiomyopathy, hypertrophic, MYH7-related | domestic cat | MYH7 | one to one | Drug |
61.0
|
| 2212 | Cardiomyopathy, hypertrophic, MYH7-related | pig | MYH7 | one to one | Drug |
61.0
|
| 2212 | Cardiomyopathy, hypertrophic, MYH7-related | rabbit | MYH7 | one to one | Drug |
61.0
|
Target evidence
Each Open Targets association between this gene and a human disease that a disease group reached.
| Human disease | Mondo | Score | Evidence |
|---|---|---|---|
| congenital myopathy 7A, myosin storage, autosomal dominant | MONDO:0008409 | 0.80 | 470 |
| MYH7-related skeletal myopathy | MONDO:0008050 | 0.78 | 444 |
| hypertrophic cardiomyopathy 1 | MONDO:0008647 | 0.76 | 679 |
Drugs
Each ChEMBL drug that acts on this gene.
| Drug | How | Latest stage |
|---|---|---|
| Mavacamten | inhibitor | Approved |
| Omecamtiv Mecarbil | activator | Approved |
| Danicamtiv | activator | Phase 2/3 |
The drug data is ChEMBL's, under CC BY-SA 3.0, and came through Open Targets release 26.09.